Testing effectiveness (Phase 2)Ended earlyNCT04096560What this trial is testingTAK-994 in Adults With Type 1 and Type 2 NarcolepsyWho this might be right forNarcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2) Takeda 97
Testing effectiveness (Phase 2)Looking for participantsNCT07096674What this trial is testingA Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaWho this might be right forNarcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia Centessa Pharmaceuticals (UK) Limited 90
Not applicableStudy completedNCT04445129What this trial is testingWake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy ParticipantsWho this might be right forHealthy VolunteersNarcolepsy Type 1 Takeda 45
Testing effectiveness (Phase 2)Looking for participantsNCT06809803What this trial is testingExtended-release Sodium Oxybate in ChildrenWho this might be right forNarcolepsy Type 1 (NT 1) Stanford University 36
Testing effectiveness (Phase 2)Ended earlyNCT04820842What this trial is testingTAK-994 in Adults With NarcolepsyWho this might be right forNarcolepsy Type 1 (NT 1) Takeda 26
Not applicableLooking for participantsNCT07006233What this trial is testingA Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic HypersomniaWho this might be right forIdiopathic HypersomniaNarcolepsy Type 1 (NT 1)Narcolepsy Type 2 (NT2) University of Sydney 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07363720What this trial is testingA Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyWho this might be right forNarcolepsy Type 1 (NT1)Narcolepsy With Cataplexy Takeda 88
Large-scale testing (Phase 3)Looking for participantsNCT06767683What this trial is testingA Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaWho this might be right forNarcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia Alkermes, Inc. 256
Early research (Phase 1)Study completedNCT06462404What this trial is testingEvaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1Who this might be right forNarcolepsy Type 1 (NT1) Eisai Inc. 22